Objective: Higher surgeon volume is associated with improved patient outcomes. This finding has prompted recommendations for increasing specialization and referrals to high-volume surgeons, yet their implementation in clinical practice has not been measured. Methods: We performed cross-sectional analyses using 1999 and 2005 discharge information from the Health Care Utilization Project National Inpatient Sample to measure whether the number of procedures performed by high-volume surgeons increased over time. Procedures included those demonstrated to have strong surgeon volume-outcome associations in the literature. International Classification of Diseases, Ninth Revision codes were employed for colorectal procedures, esophagectomy, gastrectomy, pancreatectomy, thyroidectomy, coronary artery bypass graft surgery, and carotid endarterectomy. Bivariate analyses and hierarchical generalized linear models were employed to measure association between surgeon volume and length of stay (LOS) and mortality or complications. Results: There was a significant increase in the proportion of procedures performed by high-volume surgeons over time, with the most dramatic increases seen for gastrectomy (54%), pancreatectomy (31%), and thyroidectomy (23%). Having a procedure performed by a high-volume surgeon was associated with patient race and insurance status. Overall, unadjusted mortality and LOS were significantly lower for high-volume surgeons compared with low-volume surgeons in 1999 and 2005. In multivariable hierarchical generalized linear models, only differences in LOS by surgeon volume remained significant in both years. Conclusions: The proportion of procedures performed by high-volume surgeons increased over a 6-year period, as evidence mounted in support of a surgeon volume-outcome association. Efforts are still needed to improve access among underserved subsets of the population and eliminate apparent disparities based on patient race and insurance status. (Ann Surg 2009;250: 159 -165) From the
O ver the past several decades, there has been a growing interest among health care researchers and systems in identifying the components of high-quality health care to optimize patient outcomes. The relationship between a hospital's surgical volume and patient mortality was first evaluated by Lee et al in 1957, who reported higher case-fatality rates at nonteaching institutions among patients undergoing procedures for appendicitis, perforated peptic ulcer disease, and prostatic hypertrophy. 1 Luft et al documented lower mortality rates at high-volume centers for several high-risk procedures in cardiac, vascular, and orthopedic surgery. 2 This established a precedent for further studies supporting regionalization of certain surgical procedures to high-volume hospitals. [3] [4] [5] [6] [7] [8] In 2000, the Leapfrog Group, a coalition of large employers and health care purchasers, established safety principles for their insurers, including volume standards for selected high-risk procedures, using hospital volume as a proxy for quality of care. 9, 10 Since then, studies have demonstrated an association between surgeon experience and patient outcomes that seem to be independent of hospital volume. [11] [12] [13] [14] [15] [16] [17] The purpose of this study was to measure whether the growing body of evidence showing improved outcomes for patient undergoing high-risk procedures by high-volume surgeons has had an impact on current clinical practice, referral patterns, and overall patient outcomes in the United States.
METHODS

Data Source
This study is a cross-sectional analysis comparing 1999 and 2005 patient discharge information obtained from the Health Care Utilization Project National Inpatient Sample (HCUP-NIS) administrative database. HCUP-NIS is the largest all-payer inpatient database in the United States, representing a stratified 20% sample of acute care hospitals nationwide. 18 Primary procedure and diagnosis codes from the International Classification of Diseases, Ninth Revision were employed to identify adult patients (Ն18 years) who underwent 1 of 8 oncologic or vascular procedures. Five oncologic procedures (colectomy, esophagectomy, gastrectomy, lung lobectomy, and pancreatectomy) were included if they had an associated primary diagnosis of cancer. Thyroidectomy was included for both benign and malignant disease. Patients undergoing coronary artery bypass grafting (CABG) or carotid endarterectomy (CEA) were excluded if a secondary cardiac/ peripheral vascular procedure was performed to reduce the chance of incorporating a negative outcome not due to the primary procedure. For CABG, this included cardiac valve repair or synchronous CEA; for CEA, this included synchronous procedures on heart valves or vessels.
Surgeon volume was modeled as a 3-way categorical variable: high-, medium-and low-volume groups. Medium-volume surgeons were those surgeons in between the high-and low-volume thresholds for each procedure, and were not the focus of our analysis (Table 1) . These variables were created using unique surgeon identifiers provided by HCUP-NIS. Chowdhury et al performed a meta-analysis of 163 articles published between 1957 and 2002 to examine the effects of volume of surgery and specialization on patient outcomes from 42 procedures in 13 surgical specialties. 16 High surgeon volume and surgical specialization were associated with improved patient outcome, while high hospital volume was of little benefit. Chowdhury et al's meta-analysis was employed to identify definitions of high-, medium-, and low-volume groups.
Patient demographic variables included age (18 -44, 45-64, Ն65 years); race (white, black, Hispanic, other); gender; admis-sion type (routine vs. nonroutine); median household income ($1-$35,999, $36,000 -$44,999, $45,000 -$58,999, and Ն$59,000); and payer type (Medicare, Medicaid, private HMO, self-pay). A modification of the Charlson comorbidity index was used to measure patient comorbidity. 19, 20 It was treated as an ordinal variable (1, 2, Ն3). Other independent variables included hospital location (urban vs. rural); geographic region (Northeast, Midwest, South, West); and teaching status (teaching hospital vs. nonteaching). For ease of presentation, variables in the results are described in a dichotomous fashion. Hospital volume was treated as a dichotomous variable, such that high-volume hospitals were defined as those above the 75th percentile with regard to the number of procedures performed per year.
Outcomes
The clinical outcome of interest was inpatient mortality for all procedures except thyroidectomy. Because of the low mortality rates associated with thyroidectomy, endocrine-specific complication rates were measured. These included: (1) hypoparathyroidism, hypocalcemia, or tetany and/or (2) recurrent laryngeal nerve injury, stridor, or voice disturbance. Complications were treated as a dichotomous variable (no complications vs. one or more) because it is impossible to measure complication severity using HCUP-NIS. The economic outcome of interest was mean length of hospital stay (LOS), measured in days.
Data Analysis
The proportion of patients operated on by high-and lowvolume surgeons between 1999 and 2005 were compared using the 2 -statistic for each procedure. The distribution of patient characteristics among surgeon volume groups were compared using analysis of variance for continuous variables and the 2 -statistic for categorical variables. Bivariate analyses were used to determine which variables were associated with the outcomes of interest. These analyses subsequently guided the selection of variables for adjustment in the multivariable regression models. Separate models were performed for each procedure for 1999 and 2005. Because of the large size of these models and thus complexity of results, parameter estimates are presented only for surgeon volume, adjusted for all other variables in the model. Multivariable linear regression models were used to adjust for patient and provider characteristics when predicting LOS, whereas multivariable logistic regression models were used to adjust for patient and provider characteristics for mortality (or complications for thyroidectomy). All multivariable models employed data that were clustered by surgeon and hospital to allow entry of surgeon-level (volume) and hospital-level (location, region, teaching status, and volume) variables using hierarchical generalized linear models. An interaction variable was introduced into our multivariable models to assess whether the strength of the association between surgeon volume and outcomes was consistent over time (1999 vs. 2005) .
Data analysis and management were performed using SPSS Version 14.0 (Chicago, IL). All probability values are the results of 2-sided tests, and values Ն0.05 are reported as significant. HCUP-NIS is a publicly available dataset and contains no personal identifying information. This study was deemed exempt by the Human Investigation Committee of our institution.
RESULTS
Patient Characteristics
A total of 144,994 patients were identified in HCUP-NIS as having undergone 1 of the 8 oncologic or vascular procedures in 1999 and 2005 ( Table 2 ). The most commonly performed procedures were CABG (n ϭ 32,352) and colectomy (n ϭ 20,867); the least commonly performed procedures were esophagectomy (n ϭ 539) and pancreatectomy (n ϭ 581). For most procedures, highvolume surgeons appeared to have seen more patients who were white, in a higher income bracket, and privately insured.
Surgeon Characteristics
The experience of 16,230 surgeons was analyzed. Over time, high-volume surgeons performing oncologic procedures appeared to have increased their referral base. These changes were most dramatic for gastrectomy (106% increase), lung lobectomy (100% increase), and esophagectomy (49% increase) (P Ͻ 0.001) ( Table 3) . There was a decrease in the number of vascular procedures performed by high-volume surgeons over time (CABG, 49% decrease; CEA, 19% decrease). With the exception of CABG (85% increase), there also was a decrease in the number of all procedures performed by low-volume surgeons. For CEA, medium-volume surgeons appeared to increase their share of procedures.
Patient Outcomes
In 1999, unadjusted mortality rates for high-volume surgeons were lower compared with low-volume surgeons for colectomy (1.3% vs. 3.5%; P Ͻ 0.001), esophagectomy (0% vs. 6.8%; P Ͻ 0.05), pancreatectomy (2.5% vs. 10.3%; P Ͻ 0.05), CABG (2.4% vs. 4.1%; P Ͻ 0.001), and CEA (0.5% vs. 1.0%; P Ͻ 0.05); complication rates also were lower for thyroidectomy (2.5% vs. 7.1%; P Ͻ 0.001) ( Table 4 ). By 2005, unadjusted mortality rates for high-volume surgeons remained lower than low-volume surgeons only for esophagectomy (0.6% vs. 8.8%; P Ͻ 0.05) and lung lobectomy (1.4% vs. 3.3%; P Ͻ 0.05); complication rates were still lower for thyroidectomy (4.9% vs. 7.9%; P Ͻ 0.001) ( Table 4 ).
After adjustment for patient and provider characteristics in 1999, differences in clinical outcomes between high-and lowvolume surgeons persisted for colectomy and CABG ( Table 5 ). By 2005, clinical outcomes were comparable between high-and lowvolume surgeons for all procedures. For esophagectomy and pancreatectomy, there were not enough deaths to fit adjusted clustered models, and therefore these procedures are not presented.
Significant LOS differences remained for all procedures for which differences existed in 1999 after adjusting for other patient and provider variables ( Table 6 ). The most dramatic differences were for esophagectomy (low-volume surgeons had a LOS that was 8 days longer than high-volume surgeons; P Ͻ 0.01) and pancreatectomy (low-volume surgeons had a LOS that was 10 days longer than high-volume surgeons; P Ͻ 0.01).
When an interaction variable was introduced to assess whether the strengths of associations between surgeon volume and 
Predictors of Access to High-Volume Surgeons
Access to high-volume oncologic surgeons appeared to be associated with patient race (Fig. 1 ). In 1999, 14.5% of white patients underwent their oncologic procedure by a high-volume surgeon. By 2005, 18.1% received care from high-volume surgeons (25% increase). In contrast, black patients increased their access to high-volume surgeons by only 2%, and Hispanic patients appeared to have lost access to high-volume surgeons (10% decrease).
Access to high-volume surgeons was highest among patients with private/HMO insurance, followed by Medicare (Fig. 2) . Access was lowest among patients with Medicaid. Between 1999 and 2005, patients with all payer types gained access to high-volume surgeons.
DISCUSSION
This is the first study to demonstrate that there has been an increase in the number of procedures performed by high-volume surgeons for high-risk operations for which there is known to be a positive volume-outcome association. For oncologic procedures, the proportion of patients who received care from high-volume surgeons increased significantly between 1999 and 2005. However, there was a decrease in number of vascular procedures performed by highvolume surgeons. This observation is likely related to the overall decline in the number of cardiovascular surgical procedures performed nationwide, in part as a result of improved medical therapy and endovascular alternatives. [21] [22] [23] The findings of this study confirm a positive association between surgeon volume and improved patient outcomes. Lowvolume surgeons had significantly higher unadjusted mortality/ complication rates and longer LOS than high-volume surgeons at the starting point of this study; by 2005, they persisted for esophagectomy, lung lobectomy, and thyroidectomy and LOS remained superior among high-volume surgeons for all procedures. After adjustment for patient and provider characteristics using hierarchical generalized linear models which allow for entry of surgeon and hospital-level variables, low-volume surgeons had a higher mortality rate for colectomy and CABG in 1999. By 2005, no significant differences in morbidity/mortality existed between highand low-volume surgeons, although there was a trend toward significance. Significant differences in LOS persisted for all procedures for which they were previously observed. There are several possible explanations for these findings. Despite the lack of a significant difference in mortality rates, low-volume surgeons may have higher postoperative complication rates than high-volume surgeons, necessitating a longer hospital stay by their patients. The overall decrease in mortality rates, particularly among low-volume surgeons, may in effect be the result of system-wide efforts to improve patient outcomes, such as the development of new medical technologies, rotating antibiotic schedules, and improved institutional pathways. 24 -27 Although costs were not evaluated in this study, longer LOS has been shown to be associated with total costs; because high-volume surgeons seem to have shorter LOS, they also may be more cost-efficient. 11, 12, 28 This finding would need to be validated in another study. For colectomy, low-volume surgeons may have improved their skills and quality of care over time; alternatively, they may be referring more complex cases to high-volume surgeons.
Donabedian has described 3 components of quality care: (1) structure, including adequacy of facilities and equipment, qualifications of medical staff, fiscal and administrative organization, and volume; (2) process, the appropriateness, completeness, and/or justification of clinical examination and diagnostic tests, the use of evidence-based medicine, and the coordination and continuity of patient care; and (3) outcome. 29, 30 The etiology in the differences between LOS among high-and low-volume surgeons is not clear, although both structure and process factors may play a role.
For example, high-volume surgeons may have a different threshold for operating on patients and may be better equipped to prevent, recognize, and manage postoperative complications. In a small series of patients undergoing pancreaticoduodenectomy, Maa et al demonstrated that compared with low-volume surgeons, highvolume surgeons performed more cost-effective diagnostic tests and are more likely to avoid unnecessary, invasive, and diagnostic procedures. Maa et al also showed that "exporting surgical excellence" of high-volume surgeons enhanced the quality of care at low-volume hospitals; this may be one explanation for the observed improvement of outcomes for low-volume surgeons over time in this study. 31 Similar conclusions have been found for lower risk procedures, such as parathyroidectomy, in which studies have demonstrated that high-volume surgeons were more likely to be aware of and adhere to National Institutes of Health guidelines for the management of primary hyperparathyroidism. [32] [33] [34] There is a precedent for using volume as a basis for referrals. In 2000, the Leapfrog Group proposed an evidence-based referral system using hospital volume as a proxy for outcomes; in sensitivity analyses, Birkmeyer et al projected that implementation of Leapfrog volume standards could prevent as many as 2581 surgical deaths. 9, 10 More recent studies have suggested that Leapfrog volume thresholds may not represent the optimal cut-offs between high-and lowvolume centers and that the actual benefits, on a societal level, may not be as significant as initially projected. 35, 36 Of the 8 procedures analyzed in this study, only 4 -esophagectomy, pancreatectomy, CABG, and CEA-have Leapfrog hospital volume standards. Surgeon volume standards do not yet exist, but may represent the next step in implementation of patient safety standards; this is particularly salient, given the increased awareness-from both referring providers and patients-of the potential benefits of receiving care from high-volume surgeons. 37, 38 There also is an increasing trend toward surgical specialization and subspecialization. Since 1992, there has been a significant shift toward increasing the number of subspecialty training programs and their breadth, such that currently over 70% of general surgery diplomates specialize beyond first certification. 39 For example, the number of endocrine surgery fellowships has increased to 15 (500%) over the past 5 years. Although recent studies have shown that surgical volume is a better predictor of outcomes than surgical subspecialty, fellowship training correlates to increased referral patterns and, by extension, volume. 37, 40, 41 Still, there is a relative paucity of high-volume surgeons across the United States. This has broader implications for issues of access to high-volume surgeons. For thyroidectomy, studies have shown that elderly patients and minority patients experience higher complication rates and LOS, in part because they undergo surgery more often by low-volume surgeons. 42, 43 The limitations of our study include those inherent to any administrative database. Long-term outcomes could not be addressed, as HCUP-NIS is limited to in-hospital events; each hospital admission has a unique patient identifier, precluding analysis of readmissions. The use of International Classification of Diseases, Ninth Revision procedure and diagnosis to extract patient cases from HCUP-NIS allows the potential for coding error, although this has not been shown to be pervasive in HCUP-NIS. In addition, the database lacks information regarding other factors that could influence patient access to high-volume surgeons (level of education and occupation) and outcomes (stage of disease). Technological advances for surgical procedures may play a role in outcome differences between surgeon volume groups and are difficult to capture in HCUP-NIS. The use of laparoscopy for colectomy and thoracoscopy for lung lobectomy were controlled for in adjusted analyses of mortality and LOS; use of minimally invasive surgery was not shown to have a significant effect on either outcome.
It is encouraging that more patients are being referred to high-volume surgeons, but access seems to remain a problem for certain subsets of the population. It is unclear whether this is because there are not enough high-volume surgeons, high-volume surgeons are not well distributed geographically, or appropriate referrals are not being made for all patients. Although disparities in quality of care measures between high-and low-volume surgeons have narrowed over time, progress can still be made, particularly with regard to eliminating apparent disparities based on race and payer type. Future policies must address improvement in the geographic distribution of high-volume surgeons and dissemination of new graduates of specialty training programs to underserved areas, as well as education of patients, providers, payers, and policy makers about the importance of surgeon volume for quality of care.
